To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver ...
CHICAGO -- Moderna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday. The company said two 25-microgram doses of its Covid-19 vaccine for children ages 6 ...
Moderna said Wednesday that its experimental mRNA-based seasonal flu vaccine generated a stronger immune response against four strains of the flu virus than a currently marketed vaccine in a Phase 3 ...
CAMBRIDGE, Mass. - Moderna’s COVID-19 vaccine remained 93% effective against symptomatic illness six months after the second dose, but amid the ongoing spread of the highly contagious delta variant, ...
3d
Moderna’s CMV Vaccine Extension Study Reaches Completion, Setting the Stage for Next Growth Catalyst
Moderna’s latest clinical update centers on a long‑term extension of its cytomegalovirus (CMV) vaccine program, officially titled “A Phase 2, Non-Randomized, Long-Term Extension Study to Evaluate the ...
Add Yahoo as a preferred source to see more of our stories on Google. A nurse draws up doses of the Moderna COVID-19 for a vaccination clinic in St. Helena in 2021. Moderna is offering a new, low-dose ...
You may have seen ads for a new, lower-dose Moderna COVID vaccine marketed to "the senior class" - adults 65 and older. The new vaccine, which goes by mRNA-1283 or mNexspike, was approved by the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results